Global Custom Market Research Reports Provider Company

phone

Strongbridge Biopharma plc (SBBP) - Financial and Strategic SWOT Analysis Review

  • Published Date: 13 Nov 2017
  • Number of Pages: 25
  • Category: Healthcare and Medical
  • Country: United States of America
Summary

Strongbridge Biopharma plc (Strongbridge), formerly Cortendo plc, is a commercial-stage biopharmaceutical company that develops and commercializes therapies for rare diseases. The companys marketed product, KEVEYIS (dichlorphenamide), is indicated for the treatment of hyperkalemic, hypokalemic, and related variants of primary periodic paralysis, a genetic neuromuscular disorder. Strongbridge acquired the US rights to KEVEYIS (dichlorphenamide) from a subsidiary of Taro Pharmaceutical Industries Ltd. KEVEYIS holds orphan drug designation in the US. Its pipeline products include COR-003 (levoketoconazole), a cortisol synthesis inhibitor for the treatment of endogenous Cushings syndrome; and COR-005, a novel somatostatin analog for the treatment of acromegaly, with potential use in Cushings syndrome and neuroendocrine tumors. Strongbridges primary focus is on building franchise around rare endocrine disorders including product candidates for the treatment of endogenous Cushings syndrome and acromegaly. Strongbridge is headquartered in Trevose, Pennsylvania, the US.

Strongbridge Biopharma plc Key Recent Developments

Sep 25,2017: Strongbridge Biopharma Launches the Uncovering Periodic Paralysis Genetic Testing Program
Aug 07,2017: Strongbridge Biopharma Provides Updates on KEVEYIS Launch and Recent Business Highlights, and Reports Second Quarter 2017 Financial Results
May 16,2017: Strongbridge Biopharma Provides Corporate Update and Reports First Quarter 2017 Financial Results
Mar 27,2017: Strongbridge Biopharma Provides Corporate Update and Reports Full-Year 2016 Financial Results
Dec 23,2016: Strongbridge Biopharma Provides Corporate and Financial Update

This comprehensive SWOT profile of Strongbridge Biopharma plc provides you an in-depth strategic analysis of the companys businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the companys key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalDatas Profile on Demand service, covering over 50,000 of the worlds leading companies. Once purchased, GlobalDatas highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Strongbridge Biopharma plc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,



- Business description A detailed description of the companys operations and business divisions.

- Corporate strategy Analysts summarization of the companys business strategy.

- SWOT Analysis A detailed analysis of the companys strengths, weakness, opportunities and threats.

- Company history Progression of key events associated with the company.

- Major products and services A list of major products, services and brands of the company.

- Key competitors A list of key competitors to the company.

- Key employees A list of the key executives of the company.

- Executive biographies A brief Summary of the executives employment history.

- Key operational heads A list of personnel heading key departments/functions.

- Important locations and subsidiaries A list and contact details of key locations and subsidiaries of the company.

- Key manufacturing facilities A list of key manufacturing facilities of the company.

- Detailed financial ratios for the past five years The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

- Interim ratios for the last five interim periods The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.



Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,



You get detailed information about the company and its operations to identify potential customers and suppliers.

- The profile analyzes the companys business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.



Understand and respond to your competitors business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

- The companys core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.



Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.



Scout for potential investments and acquisition targets, with detailed insight into the companies strategic, financial and operational performance.

- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.



Gain key insights into the company for academic or business research.

- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Publisher Name : GlobalData
Table of Contents


Section 1 - About the Company



Strongbridge Biopharma plc - Key Information

Strongbridge Biopharma plc - Overview

Strongbridge Biopharma plc - Key Employees

Strongbridge Biopharma plc - Key Employee Biographies

Strongbridge Biopharma plc - Key Operational Heads

Strongbridge Biopharma plc - Major Products and Services

Strongbridge Biopharma plc - History

Strongbridge Biopharma plc - Company Statement

Strongbridge Biopharma plc - Locations And Subsidiaries

Strongbridge Biopharma plc - Key Manufacturing facilities

Head Office

Other Locations & Subsidiaries



Section 2 - Company Analysis



Strongbridge Biopharma plc - Business Description

Strongbridge Biopharma plc - Corporate Strategy

Strongbridge Biopharma plc - SWOT Analysis

SWOT Analysis - Overview

Strongbridge Biopharma plc - Strengths

Strongbridge Biopharma plc - Weaknesses

Strongbridge Biopharma plc - Opportunities

Strongbridge Biopharma plc - Threats

Strongbridge Biopharma plc - Key Competitors



Section 3 - Company Financial Performance Charts



Strongbridge Biopharma plc - Financial Ratios

Financial Ratios - Capital Market Ratios

Financial Ratios - Annual Ratios

Financial Ratios - Interim Ratios

Financial Ratios - Ratio Charts



Section 4 - Appendix



Appendix

Methodology

Ratio Definitions

About GlobalData

Contact Us

Disclaimer





Note*: Some sections may be missing if data is unavailable for the company

List Of Tables




Strongbridge Biopharma plc, Key Information

Strongbridge Biopharma plc, Key Ratios

Strongbridge Biopharma plc, Share Data

Strongbridge Biopharma plc, Major Products and Services

Strongbridge Biopharma plc, History

Strongbridge Biopharma plc, Key Employees

Strongbridge Biopharma plc, Key Employee Biographies

Strongbridge Biopharma plc, Key Operational Heads

Strongbridge Biopharma plc, Other Locations

Strongbridge Biopharma plc, Subsidiaries

Strongbridge Biopharma plc, Key Manufacturing facilities

Strongbridge Biopharma plc, Key Competitors

Strongbridge Biopharma plc, SWOT Analysis

Strongbridge Biopharma plc, Ratios based on current share price

Strongbridge Biopharma plc, Annual Ratios

Strongbridge Biopharma plc, Interim Ratios

Currency Codes

Capital Market Ratios

Equity Ratios

Profitability Ratios

Cost Ratios

Liquidity Ratios

Leverage Ratios

Efficiency Ratios

List Of Figures




Strongbridge Biopharma plc, Performance Chart

Strongbridge Biopharma plc, Ratio Charts

Strongbridge Biopharma plc (Strongbridge), formerly Cortendo plc, is a commercial-stage biopharmaceutical company that develops and commercializes therapies for rare diseases. The companys marketed product, KEVEYIS (dichlorphenamide), is indicated for the

View Report
There is no reviews available for this report

Select License Type

Delivery Details

Delivery Details : Electronic files (PDF) of market research reports will dispatched within 12 to 24 hours. (Mon-Fri IST)

Customized Report

If a particular report is not as per your requirement you can ‎choose "Customized Report". To visit click on -

Custom Research Reports